Abstract
Recent data have shown that the purinergic receptor P2X4 plays key roles in inflammatory responses. We evaluated whether P2X4 inhibition could affect the development of arthritis and autoimmunity in collagen-induced arthritis (CIA) model. P2X4 antisense oligonucleotide (asODN) was injected intravenously via tail vein into the CIA mice to selectively inhibit P2X4 expression daily for 14 days. P2X4 asODN treatment reduced the clinical score of CIA in mice. P2X4 asODN also decreased the levels of serum IL-1β, TNF-α, IL-6, and IL-17. P2X4 asODN treatment significantly inhibited synovial inflammation and joint destruction. P2X4 asODN treatment also suppressed the NLR family, pyrin domain containing 1 (NLRP1) inflammasome activation in CIA mice and synovial cells of human rheumatoid arthritis. These data show that P2X4 asODN confers a therapeutic benefit on CIA. Inhibition of the NLRP1 inflammasome signaling pathway is the underlying mechanism of action.
Similar content being viewed by others
References
Straub, R.H., and J.R. Kalden. 2009. Stress of different types increases the proinflammatory load in rheumatoid arthritis. Arthritis Research & Therapy 11: 114.
Braun, T., and J. Zwerina. 2011. Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis. Arthritis Research & Therapy 13: 235.
North, R.A., and E.A. Barnard. 1997. Nucleotide receptors. Current Opinion in Neurobiology 7: 346–357.
Guo, L.H., and H.J. Schluesener. 2005. Lesional accumulation of P2X4 receptor macrophages in rat CNS during experimental autoimmune encephalomyelitis. Neuroscience 134: 199–205.
Raouf, R., A.J. Chabot-Doré, A.R. Ase, D. Blais, and P. Séguéla. 2007. Differential regulation of microglial P2X4 and P2X7 ATP receptors following LPS-induced activation. Neuropharmacology 53: 496–504.
Sakaki, H., T. Fujiwaki, M. Tsukimoto, A. Kawano, H. Harada, and S. Kojima. 2013. P2X4 receptor regulates P2X7 receptor-dependent IL-1β and IL-18 release in mouse bone marrow-derived dendritic cells. Biochemical and Biophysical Research Communications 15(432): 406–411.
Dowling, J.K., and L.A. O’Neill. 2012. Biochemical regulation of the inflammasome. Critical Reviews in Biochemistry and Molecular Biology 47: 424–443.
van Bruggen, R., M.Y. Köker, M. Jansen, M. van Houdt, D. Roos, T.W. Kuijpers, et al. 2010. Human NLRP3 inflammasome activation is Nox1-4 independent. Blood 115: 5398–5400.
Shin, M.S., Y. Kang, N. Lee, E.R. Wahl, S.H. Kim, K.S. Kang, et al. 2013. Self double-stranded (ds)DNA induces IL-1β production from human monocytes by activating NLRP3 inflammasome in the presence of anti-dsDNA antibodies. Journal of Immunology 190: 1407–1415.
Ben Hamad, M., F. Cornelis, S. Marzouk, G. Chabchoub, Z. Bahloul, A. Rebai, et al. 2012. Association study of CARD8 (p.C10X) and NLRP3 (p.Q705K) variants with rheumatoid arthritis in French and Tunisian populations. International Journal of Immunogenetics 39: 131–136.
Jin, Y., C.M. Mailloux, K. Gowan, S.L. Riccardi, G. LaBerge, D.C. Bennett, et al. 2007. NALP1 in vitiligo-associated multiple autoimmune disease. New England Journal of Medicine 356: 1216–1225.
Sui, J., H. Li, Y. Fang, Y. Liu, M. Li, B. Zhong, et al. 2012. NLRP1 gene polymorphism influences gene transcription and is a risk factor for rheumatoid arthritis in Han Chinese. Arthritis and Rheumatism 64: 647–654.
Chiba, A., M. Mizuno, C. Tomi, R. Tajima, I. Alloza, A. di Penta, et al. 2012. A 4-trifluoromethyl analogue of celecoxib inhibits arthritis by suppressing innate immune cell activation. Arthritis Research & Therapy 14: R9.
Tsuda, M., Y. Shigemoto-Mogami, S. Koizumi, A. Mizokoshi, S. Kohsaka, M.W. Salter, et al. 2003. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424: 778–783.
Le Goff, B., E. Soltner, C. Charrier, Y. Maugars, F. Rédini, D. Heymann, et al. 2009. A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis. Arthritis Research & Therapy 11: R185.
Alqallaf, S.M., B.A. Evans, and E.J. Kidd. 2009. Atypical P2X receptor pharmacology in two human osteoblast-like cell lines. British Journal of Pharmacology 156: 1124–1135.
Tak, P.P., and B. Bresnihan. 2000. The pathogenesis and prevention of joint damage in rheumatoid arthritis: Advances from synovial biopsy and tissue analysis. Arthritis and Rheumatism 43: 2619–2633.
Dayer, J.M. 2003. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Rheumatology (Oxford, England) 42(Suppl 2): ii3–ii10.
Kudo, O., Y. Fujikawa, I. Itonaga, A. Sabokbar, T. Torisu, and N.A. Athanasou. 2002. Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation. The Journal of Pathology 198: 220–227.
Lettesjö, H., E. Nordström, H. Ström, B. Nilsson, B. Glinghammar, L. Dahlstedt, et al. 1998. Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scandinavian Journal of Immunology 48: 286–292.
Holt, I., R.G. Cooper, J. Denton, A. Meager, and S.J. Hopkins. 1992. Cytokine inter-relationships and their association with disease activity in arthritis. British Journal of Rheumatology 31: 725–733.
Zhang, Y., G. Ren, M. Guo, X. Ye, J. Zhao, L. Xu, et al. 2013. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model. International Immunopharmacology 15: 199–205.
Stamp, L.K., M.J. James, and L.G. Cleland. 2004. Interleukin-17: The missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis? Immunology and Cell Biology 82: 1–9.
Park, M.J., H.S. Park, H.J. Oh, J.Y. Lim, B.Y. Yoon, H.Y. Kim, et al. 2012. IL-17-deficient allogeneic bone marrow transplantation prevents the induction of collagen-induced arthritis in DBA/1J mice. Experimental & Molecular Medicine 44: 694–705.
Magitta, N.F., A.S. Bøe Wolff, S. Johansson, B. Skinningsrud, B.A. Lie, K.M. Myhr, et al. 2009. A coding polymorphism in NALP1 confers risk for autoimmune Addison’s disease and type 1 diabetes. Genes and Immunity 10: 120–124.
Levandowski, C.B., C.M. Mailloux, T.M. Ferrara, K. Gowan, S. Ben, Y. Jin, et al. 2013. NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome. Proceedings of the National Academy of Sciences of the United States of America 110: 2952–2956.
Conflict of interest
All authors declare no conflicts of interest in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, F., Guo, N., Ma, Y. et al. Inhibition of P2X4 Suppresses Joint Inflammation and Damage in Collagen-Induced Arthritis. Inflammation 37, 146–153 (2014). https://doi.org/10.1007/s10753-013-9723-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-013-9723-y